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Risk Factors for Cerebral Embolization after Carotid Artery Stenting with
Embolic Protection – A DW–MRI Study in 827 Patients
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Background: Carotidendarterectomy and CAS appear to have similar overall perioper-
ative stroke rates, which, however, may differ in specific patient subgroups. Knowledge
of the risk factors for cerebral embolic events during CAS may impact treatment decisions
for the individual patient, but have not been extensively studied.Aim of the study was to
evaluate the risk factors for cerebral embolization after carotid artery stenting with
embolic protection.
Methods: Out of 837 consecutive patients undergoing CAS with cerebral embolic
protection pre- and post-procedural diffusion weighted magnetic resonance imaging
(DW-MRI) was performed for evaluation of new cerebral ischemic lesions in 728 patients
(86.9%). Multivariate logistic regression analyses were performed to identify factors
predictive for embolic events.
Results: New ischemic lesions were found in 32.8 % of the patients. Age, hypertension,
lesion length, lesion excentricity, and aortic arch type III were significantly associated
with new ischemic lesions, calcified lesions were negatively associated. In 25% of patients
with embolic events lesions were also found in the contralateral hemisphere. Predictive
factors for contralateral lesions were age,  50% stenosis of the contralateral internal
carotid artery, and an aortic arch type II, with a trend for aortic arch type III.
Conclusions: Age, hypertension, lesion morphology, and aortic arch type were predic-
tive for procedural related cerebral embolic events during embolic protected CAS. Age,
significant contralateral carotid stenosis and complex aortic arch type were predictive for
contralateral ischemic events. These findings may help to find the optimal treatment
decision for the individual patient with carotid artery stenosis.
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Peri-procedural Outcomes After Carotid Artery Stenting with the First 15,000
Patients Enrolled in the SAPPHIRE Worldwide Study
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Background: Further study is needed to determine which patient characteristics and
lesion criteria derive the greatest benefit from carotid artery stenting (CAS). SAPPHIRE
Worldwide is a large scale multicenter post-approval study to evaluate CAS with distal
embolic protection using the Cordis PRECISE® Nitinol Stent and ANGIOGUARD™
XP/RX Emboli Capture Guidewire.
Methods: Patients were enrolled with either symptomatic stenosis 50% or asymptom-
atic stenosis 80% and considered at high risk for surgery. Inclusion criteria included
adherence to current FDA-approved labeling with these devices. The primary endpoint of
major adverse events (MAE) at 30 days included any death, myocardial infarction or
stroke.
Results: Enrollment began October, 2006 and is ongoing. Data were previously reported
on 10,008 patients, of whom 2,963 (30%) were symptomatic and 7,045 (70%) were
asymptomatic. Overall, the MAE rate at 30 days was 4.5% (death 1.3%, MI 0.6%, stroke
3.3%). There was a significant increase in the combined rate of stroke or death at 30 days
between symptomatic and asymptomatic patients (6.2% vs. 3.8%, p0.0001), and
patients 75 years of age and older compared to younger patients (5.9% vs. 3.3%,
p0.0001). The 30-day stroke or death rate did not differ significantly among operator
experience or volume of centers. To date, 15,000 patients have been enrolled and
completed 30-day follow-up. Final data will be available and presented on the 15,000
patients at time of presentation.
Conclusions: These data compare favorably to other reports of CAS in a high-surgical
risk population and are similar to results recently reported in the CREST trial comparing
CAS to surgery in a non-high surgical risk population.
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Early results of multicenter, prospective trial of TEVAR for blunt thoracic
aortic injury (RESCUE Trial)
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Background: Outcome of patients with blunt aortic injury undergoing endovascular
repair is poorly understood. The aim of this study is to evaluate the early outcome of
patients undergoing TEVAR for blunt aortic injuries.
Methods: A prospective, non-randomized, multicenter trial using Medtronic Valiant
Captivia was conducted at 20 sites. 50 patients with blunt aortic injury were enrolled
between April 2010 and January 2012. The primary endpoint was 30-day all-cause
mortality. Secondary endpoints were 30-day adverse events related to the procedure,
device or aorta, aortic-related mortality and successful device delivery/deployment.
Results: 38/50(76%) were male with mean age of 40.7 17.4 years. 52 stent grafts were
implanted within a median of 1.0 day following injury (mean 1.8 4.0 days). 70%(35/50)
of aortic injuries were grade 3 or higher. Mean injury severity score was 37.6  14.3.
38/52 (74%) of stent grafts were 28 mm. The left subclavian artery was completely
covered in 40% of patients (20/50) and partially covered in 18% of patients (9/50). One
patient with partial coverage underwent subclavian artery revascularization. Cerebral
spinal fluid was drained in 2 patients. The median procedure time was 90.5 minutes, and
median hospital stay was 11 days. There was 100% successful device delivery/
deployment.
Conclusions: Based on the early outcomes, TEVAR using the Valiant Captivia appears
to be a promising treatment modality for blunt thoracic aortic injuries.
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Impact of Catheter Fragmentation followed by Local Intrapulmonary
Thrombolysis in Acute High risk Pulmonary Embolism as Primary Therapy:
Acute and Long term outcomes
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Background: Massive Pulmonary embolism (PE) requires prompt reperfusion to prevent
progressive hemodynamic decline and death. We report our single center experience on
immediate and long-term outcomes in high risk PE patients treated with mechanical
fragmentation followed by intrapulmonary thrombolysis as a primary therapy.
Methods: 50 consecutive high risk PE patients defined as shock index (heart rate /systolic
blood pressure) 1, 50% pulmonary arterial obstruction and pulmonary hypertension
(mean pulmonary arterial pressures (PAP) 25 mm Hg) underwent emergent mechanical
reperfusion by standard pigtail catheter; followed by intrapulmonary infusion of urokinase
over 24 hours. After discharge, transthoracic echocardiography (TTE) was done at 3. 6
and 12 months.
Results: Mechanical thrombectomy restored antegrade flow in all patients. The average
heart rate, mean PAP, Miller score, Shock index decreased significantly from 125 
18bpm, 41 8 mmHg, 20 5, 1.32 0.3 to 93 13 bpm, 24 7 mmHg, 5 2, 0.79
0.2 respectively after 24 hrs (P  0.0001). A significant increase was observed in
mean blood pressure and O2 saturation (78 12 mm Hg vs. 92 11 mm Hg, 90% 
7% vs. 98%  2% respectively p  0.0001). Inhospital mortality was 4% (2/50 pts)
and major bleeding complications (local hematoma requiring blood transfusion) were
seen in 2 patients. Sequential TTE based estimation of pulmonary arterial systolic
pressure showed a statistically significant linear trend of reduction from 62 11 mm
Hg at presentation to 23 6 mm Hg at 12 months.
Conclusions: Our results show that mechanical fragmentation followed by intrapulmo-
nary thrombolysis can be offered as a primary therapy for high risk PE patients in
experienced centers, similar to approach with coronary revascularization.
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Efficacy of Cardiatis Multilayer Flow Modulator in Peripheral and
Visceral Aneurysms Repair: Italian Multicenter Registry Results at One
Year Follow Up
maria antonella ruffino1, claudio rabbia1
1San Giovanni Battista Hospital, Torino, Italy
Background: to show results of Cardiatis Multilayer Stent (CMPS) in peripheral (PAA)
and visceral aneurysms (VAA) repair with/without collateral branches after one year FU.
Methods: between May 2009 and June 2010, 54 patients with PAA (35) and VAA (19)
were treated with CMPS. Early (30 days), 6 months and 12 months results were analysed
in terms of aneurysm thrombosis, stent and side branches patency, and shrinkage. All data
were recorded in the Italian Registry of Cardiatis Procedures.
Results: intraoperative immediate technical success was achieved in all the cases.
Clinical success was evaluated with CT-angiography. Complete aneurysm thrombosis
rate at 1,6, and 12 month FU was 86.5% (45/52 patients), 94.2% (49/52 patients), and
93.3% (42/45 patients) respectively. Side branches patency rate was 98.1 (51/52) at 1 and
6 months, and 97.8% (44/45) at 12 months, with a stent patency rate of 94.2% (49/52) at
1 and 6 months, and 91.1% (41/45) at 12 months. We could analyse shrinkage at each
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scheduled control in 41/45 patients. At all scheduled controls shrinkage was statistically
significant. The mean size of 41 lesions evaluated at presentation, one, six and twelve
months follow up was 34.12 mm (9-80, SD15.52), 29.93 mm (6-70, SD14.86), 29.10
mm (6-70, SD14.96) and 26.88 (6-63, SD15.39) respectively. Diameter reduction rate
was 15.5%, 3.8% and 11% at 1, 6 and 12 months (statistically significant: p0.05).
Presence of mural thrombus did not influence shrinkage timing (p0.05), while complex
lesion anatomy (presence of side branches) delay shrinkage (p0.05).
Conclusions: data at one year FU show that CMPS is an effective device for repair of
PAA and VAA with/without collateral branches, with significant shrinkage of the sac,
allowing a broader group of patients to be treated with endovascular repair with results
comparable to other traditional endovascular technique.
TCT-6
Biodegradable polymer-based Biolimus A9-eluting stent for the treatment of
infrapopliteal arteries in critical limb ischemia: long-term clinical and
angiographic follow-up.
Eugenio Stabile1, Luigi Salemme1, Giovanni Sorropago1, Angelo Cioppa1,
Vittorio Ambrosini1, Grigore Popusoi1, Armando Pucciarelli1, Linda Cota1,
Tullio Tesorio1, Paolo Rubino1
1Clinica Montevergine, Mercogliano, Italy
Background: To present angiographic and clinical results of a retrospective registry
assessing the performance of a biodegradable polymer-based Biolimus A9-eluting stent
(BES) in the treatment of focal below the knee atherosclerotic disease.
Methods: From 05/2009 to 05/2011, 25 patients (17 men; mean age 71.8  6.7 years)
with chronic lower limb ischemia (Rutherford categories 3-6) underwent primary BES
placement in focal infrapopliteal lesions. Dual antiplatelet theraphy (DAPT) was pre-
scribed for six month. The primary endpoint was freedom from angiographic in-stent
stenosis (ISRS) 50%. Clinical endpoints were death, amputation, and bypass surgery.
Results were correlated with patient and lesion characteristics and cumulative outcomes
were assessed with Kaplan-Meier analysis.
Results: Technical success was achieved in all cases. Freedom from ISRS were 100 %
after 6 months, 96.0% after 12 months, and 92.0% at 12 months. No stent occlusions
occurred. During clinical follow-up of 25 patients over a mean 14 6 months, there were
no deaths, no mayor amputations, and no need for bypass surgery. Clinical status
improved in all the patients.
Conclusions: Treatment of focal infrapopliteal lesions with BES showed encouraging
angiographic results in this registry. Clinical improvement was robust and particualry
evident in CLI patients. Six months of DAPT were sufficient to prevent stent thrombosis.
Further studies are needed to evaluate the potential clinical benefit of BES as compared
to balloon angioplasty or bare metal stents in the treatment of infrapopliteal lesions.
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Plaque Excision as a Treatment Option for Critical Limb Ischemia: 1-Year
Results of the DEFINITIVE LE Study
James McKinsey1, Thomas Zeller2, Lawrence Garcia3
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Background: The endovascular treatment of patients with critical limb ischemia (CLI)
is complex and poorly studied. Plaque excision allows the debulking of the atherosclerotic
plaque without the need of leaving a foreign body behind. The DEFINITIVE LE study
was a global study that assessed the effectiveness of plaque excision using the Silver-
Hawk® and TurboHawkTM Systems (Covidien/ev3, Plymouth, MN) for PAD in
femoropopliteal and tibial-peroneal arteries with specific evaluation of patients with
claudication and CLI.
Methods: The DEFINITIVE LE study enrolled 200 patients (278 lesions) with CLI who
underwent revascularization with plaque excision. . Endpoints were assessed by indepen-
dent core laboratories. The primary endpoint for CLI patients was freedom from major
unplanned amputation of the target limb at 1 year.
Results: In 200 patients in the DEFINITIVE LE study with CLI, mean age was 72.1
years, 50% were male, and 69.0% had diabetes. Other frequent comorbidities included
hypertension (92.5%), hyperlipidemia (76.5%) and renal insufficiency (24.0%). The mean
lesion length was 7.1 cm and 24.5% of lesions were 10 cm. The mean baseline stenosis
was 75.8% and 36.8% of lesions were calcified. At 6 months and at 1 year, freedom from
amputation was 97.3% and 95.8%,. Primary patency was 86.9% at 6 months and 69.2%
at 1 year. Other secondary endpoints demonstrated significant, sustained improvements as
shown below.
Outcome Baseline
3-Month
Follow-Up
6-Month
Follow-Up
12-Month
Follow-Up
Rutherford Clinical
Category
RCC 4 37.00% n/a 2.10% 5.30%
RCC 5 53.00% n/a 21.00% 14.30%
RCC 6 10.00% n/a 5.60% 4.50%
Ankle-Brachial
Index
0.59 0.18 n/a 0.70 0.26 0.78 0.26
EQ-5D Score 0.64 0.22 n/a 0.74 0.21 0.74 0.21
EQ-5D Visual
Analog
60.2 20.8 n/a 68.3 19.2 70.2 18.1
Wound Healing
(Wagner scale)
0 1.80% 51.70% 62.40% 72.20%
1 54.60% 25.00% 28.60% 17.40%
2 19.60% 10.00% 3.00% 4.30%
3 6.10% 5.00% 1.50% 0.90%
4 16.00% 6.70% 4.50% 1.70%
5 1.80% 1.70% 0.00% 3.50%
Conclusions: Plaque excision for CLI results in high rates of limb salvage and good
primary patency at 1 year, as well as improvements in wound healing, clinical status as
measured by RCC and ABI, and improved quality of life for this challenging patient
population. This was accomplished with a very low rate of stent use which would allow
for future intervention with new technology that may be excluded if a stent were in place.
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Morphological assessment of renal arteries after radiofrequency catheter-
based sympathetic denervation in a porcine model
Michael Joner1, Kristin Steigerwald2, Karl-Ludwig Laugwitz3
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Background: Catheter-based renal artery denervation has been successfully introduced
as alternative treatment for patients suffering from drug-resistant essential hypertension.
However, the local morphological changes within the vessel wall accompanying this
technique remain elusive and we sought to characterize these by utilizing the Simplicity®
(Medtronic Ardian, Mountain View, CA, USA) radiofrequency catheter approach.
Methods: Following treatment of seven pigs, renal arteries were assigned to either the
acute (n6), sub-acute (10-day follow-up, n6) or control (untreated, n2) group. At
follow-up blood analysis, final angiography and optical coherence tomography (OCT)-
imaging of the treated arteries were performed and renal arteries and kidneys were
processed for histopathology and immunohistochemistry.
Results: Radiofrequency derived energy application to the vessel wall induced transmu-
ral tissue coagulation and loss of endothelium resulting in local thrombus formation also
detectable by OCT. At 10 days, the luminal surface was almost completely re-
endothelialized. Mural wall damage was replaced by fibrotic tissue and the adventitial
layer showed strong inflammatory infiltration including vasculogenesis. Remnant auto-
nomic nerve fascicles within the lesion segments of the sub-acute group displayed
enhanced vacuolic degeneration and an impaired neurofilament protein immunostaining
pattern. Examination of the kidneys revealed no abnormalities and blood parameters
remained within the physiological range.
Conclusions: Catheter-based application of radiofrequency energy resulted in circum-
scribed transmural injury within the arterial wall affecting autonomic nerve fascicles in a
delayed manner. Acute loss of endothelialization resulted in thrombus formation leaving
kidney perfusion unimpaired.
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